ATE28477T1 - Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen. - Google Patents

Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen.

Info

Publication number
ATE28477T1
ATE28477T1 AT85400080T AT85400080T ATE28477T1 AT E28477 T1 ATE28477 T1 AT E28477T1 AT 85400080 T AT85400080 T AT 85400080T AT 85400080 T AT85400080 T AT 85400080T AT E28477 T1 ATE28477 T1 AT E28477T1
Authority
AT
Austria
Prior art keywords
muramylpeptide
combined
hapten
antigen
muramylpeptides
Prior art date
Application number
AT85400080T
Other languages
English (en)
Inventor
Claude Leclere
Georges Bahr
Louis Chedid
Original Assignee
Anvar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anvar filed Critical Anvar
Application granted granted Critical
Publication of ATE28477T1 publication Critical patent/ATE28477T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85400080T 1984-01-17 1985-01-17 Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen. ATE28477T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8400676A FR2558165B1 (fr) 1984-01-17 1984-01-17 Nouveaux conjugues d'oligo-muramylpeptides et compositions biologiques les contenant pour l'activation des macrophages
EP85400080A EP0149581B1 (de) 1984-01-17 1985-01-17 Oligo-Muramylpeptide enthaltende Zubereitungen und ihre Verwendung, insbesondere für die Aktivierung von Makrophagen

Publications (1)

Publication Number Publication Date
ATE28477T1 true ATE28477T1 (de) 1987-08-15

Family

ID=9300201

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85400080T ATE28477T1 (de) 1984-01-17 1985-01-17 Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen.

Country Status (5)

Country Link
EP (1) EP0149581B1 (de)
JP (1) JPS60161926A (de)
AT (1) ATE28477T1 (de)
DE (1) DE3560366D1 (de)
FR (1) FR2558165B1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A3 (de) * 1984-03-01 1987-07-01 Centocor, Inc. Steigerung der Antigenimmunogenität mittels Antikörper
US4879225A (en) * 1986-06-20 1989-11-07 Neorx Corporation Enhanced production of antibodies utilizing insolubilized immune complexes
CN1034986C (zh) * 1993-04-22 1997-05-28 上海医科大学 一种新型免疫原性复合物制剂及制备方法
JP3669758B2 (ja) * 1995-06-15 2005-07-13 ユニ・チャーム株式会社 蓋装置
EP3323424A1 (de) 2016-11-17 2018-05-23 Cyanimal IP Cyaa-polypeptide als immunomodulatorenverstärker

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1138436A (en) * 1978-02-24 1982-12-28 Gerhard Baschang Process for the manufacture of novel antigens
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant

Also Published As

Publication number Publication date
DE3560366D1 (en) 1987-08-27
EP0149581B1 (de) 1987-07-22
JPS60161926A (ja) 1985-08-23
FR2558165A1 (fr) 1985-07-19
EP0149581A3 (en) 1985-08-28
FR2558165B1 (fr) 1986-07-04
EP0149581A2 (de) 1985-07-24

Similar Documents

Publication Publication Date Title
DE3580420D1 (de) 1,10-phenanthrolin-2,9-dicarbonsaeure-derivate und deren verwendung fuer fluoreszens-immunoassay.
HUT59322A (en) Ultrasonic contrast materials, process for producing them and for using them as diagnostic and therepeutic agents
DE69022760D1 (de) Allgemeinverfahren für die Bestätigung von Krebs.
DE3764770D1 (de) Anordnung fuer die dosierung von kraftstoff sowie dosiervorrichtung dafuer.
IT8621232A0 (it) Copolimeri silitati dell'isobutilene reticolabili in condizioni ambientali eprocedimento per la loro preparazione.
IT8719773A0 (it) Anello d'attrito per frizioni oppure per freni, procedimento e dispositivo per la realizzazione dell'anello d'attrito stesso.
DE3583998D1 (de) Polyimidvorlaeufer-harzzusammensetzung und halbleiterkomponente, die dieselbe verwendet.
IT7883451A0 (it) Fune d' acciaio-alluminio particolarmente idonea per la conduzione di elettricita' eprocedimento per la produzione ditale fune.
DE3863195D1 (de) Feste base, verfahren zu deren herstellung und ihre anwendung fuer die herstellung von olefinen mit innerer doppelbindung.
DE3579676D1 (de) Zusammengesetzte harzteilchen, ihre herstellung und harzmasse fuer ueberzugszwecke die diese enthaelt.
ATE28477T1 (de) Oligo-muramylpeptide enthaltende zubereitungen und ihre verwendung, insbesondere fuer die aktivierung von makrophagen.
AT359763B (de) Vorrichtung, insbesondere fuer die bearbeitung von rasenflaechen u.dgl.
IT8019874A0 (it) Nuovi portamonete, borse e simili, e loro procedimento di fabbricazione.
IT8023483A0 (it) Procedimento per la produzione per via silicotermica, in siviera, di leghe a base di manganese e di silicio.
JPS57122054A (en) Tridecapeptide and manufacture
DE3670632D1 (de) Histamin-derivate, immunogen-konjugate und dadurch induzierte antikoerper.
IT1082078B (it) Procedimento per la fabbricazione di tamponi mestruali e tamponi cosi' costituiti
DE3856007D1 (de) Lichtfilter für die mikroelektronik
EP0374946A3 (de) Verfahren zum Nachweis von kohlenhydrathaltigen Verbindungen
ATE58295T1 (de) Zubereitung mit gehalt an einem antiprogestomimetischen und einem uterotonischen stoff.
BR7704900A (pt) Processo para a preparacao de o-etil-s-n-propil-o-2,2,2-trihalogeno-etilfos-fotiolatos(ou tionotiolatos)e composicao inseticida,acaricida ou nematocida a base destes
IT1115507B (it) Specchio convergente,in particolare per "centrali solari",procedimento per la sua fabbricazione e dispositivo per l'attuazione del detto procedimento
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
EP0394644A3 (de) Halogenbenzolderivate
ATE83930T1 (de) Antikoerper enthaltende stabilisierte waesserige zusammensetzung.